Rosane Gomes de Paula Queiroz
Overview
Explore the profile of Rosane Gomes de Paula Queiroz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
218
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Santis J, de Sousa G, Queiroz R, Candido M, Almeida F, de Rezende C, et al.
Hum Cell
. 2025 Feb;
38(2):55.
PMID: 39960575
Medulloblastoma (MB) is the most common malignant brain tumor in children, comprising four distinct subgroups: wingless (WNT), sonic hedgehog (SHH), Group 3, and Group 4. MYC amplification and metastatic dissemination...
2.
Chagas P, Veronez L, de Sousa G, Cruzeiro G, Correa C, Saggioro F, et al.
Hum Cell
. 2023 Jul;
36(6):2129-2139.
PMID: 37460706
Groups (Grp) 3 and 4 are aggressive molecular subgroups of medulloblastoma (MB), with high rates of leptomeningeal dissemination. To date, there is still a paucity of biomarkers for these subtypes...
3.
Nascimento D, Silva I, Lima C, Cavalcanti A, Roberti L, Queiroz R, et al.
Autoimmunity
. 2022 Sep;
55(8):515-519.
PMID: 36177494
Childhood- onset systemic lupus erythematosus (cSLE) is a multisystem inflammatory disease that can lead to severe clinical conditions resulting in early comorbidities. Several genetic, environmental, and immunological factors are known...
4.
de Almeida Magalhaes T, Cruzeiro G, de Sousa G, Englinger B, Nagano L, Ancliffe M, et al.
Neuro Oncol
. 2022 May;
25(1):185-198.
PMID: 35640920
Background: Supratentorial RELA fusion (ST-RELA) ependymomas (EPNs) are resistant tumors without an approved chemotherapeutic treatment. Unfortunately, the molecular mechanisms that lead to chemoresistance traits of ST-RELA remain elusive. The aim...
5.
Martins-da-Silva A, Baroni M, Salomao K, das Chagas P, Bonfim-Silva R, Geron L, et al.
Cell Mol Neurobiol
. 2022 Apr;
43(2):813-826.
PMID: 35366170
Medulloblastoma is the most common type of pediatric malignant primary brain tumor, and about one-third of patients die due to disease recurrence and most survivors suffer from long-term side effects....
6.
Cruzeiro G, de Almeida Magalhaes T, de Sousa G, Bonfim Silva R, de Biagi Junior C, das Chagas P, et al.
Cancers (Basel)
. 2021 Dec;
13(24).
PMID: 34944872
Advances in genomics have led to the identification of twelve relevant molecular subtypes within medulloblastoma (MB). The alpha subtype of Sonic hedgehog-driven MB is resistant to therapy (including smoothened inhibitors)...
7.
de Carvalho L, de Sousa G, Moura R, Saggioro F, Facincani I, Costa R, et al.
Rheumatology (Oxford)
. 2021 Dec;
61(4):e84-e86.
PMID: 34864870
No abstract available.
8.
das Chagas P, de Sousa G, Veronez L, Martins-da-Silva A, Correa C, Cruzeiro G, et al.
J Mol Neurosci
. 2021 Nov;
72(3):633-641.
PMID: 34822110
The Group 3 Medulloblastoma (Grp3-MB) is an aggressive molecular subtype with a high incidence of metastasis and deaths. In this study, were used an RNA sequencing data (RNA-Seq) from a...
9.
de Sousa G, Lira R, de Almeida Magalhaes T, da Silva K, Nagano L, Saggioro F, et al.
J Mol Med (Berl)
. 2021 Apr;
99(8):1101-1113.
PMID: 33903940
Although ependymoma (EPN) molecular subgroups have been well established by integrated high-throughput platforms, low- and middle-income countries still need low-cost techniques to promptly classify these molecular subtypes. Here, we applied...
10.
Frequency of the TP53 p.R337H mutation in a Brazilian cohort of pediatric patients with solid tumors
Feitosa J, das Chagas P, de Sousa G, Queiroz R, Cruzeiro G, Tone L, et al.
Mol Biol Rep
. 2020 Jul;
47(8):6439-6443.
PMID: 32671623
TP53 p.R337H germline mutation is highly prevalent in the Southern region of Brazil. We sought to investigate TP53 p.R337H mutation in pediatric tumor samples from a population settled in a...